ravuconazole and Tinea

ravuconazole has been researched along with Tinea* in 3 studies

Other Studies

3 other study(ies) available for ravuconazole and Tinea

ArticleYear
Antifungal Susceptibility Testing for Microsporum canis from Cats in Japan.
    Medical mycology journal, 2023, Volume: 64, Issue:1

    Control of infection caused by Microsporum canis in pet animals are important for prevention of zoonosis. Treatments for animal dermatophytosis have generally consisted of itraconazole (ITZ) and terbinafine (TRF); however, a TRF-resistant M. canis strain from a case of feline dermatophytosis has been reported. In the present study, we examined the in vitro susceptibility of clinical isolates of M. canis to new antifungal drugs, such as ravuconazole (RVZ) and luliconazole (LCZ). The results indicated that RVZ and LCZ are more effective than ITZ and TRF. Therefore, oral administration of RVZ or topical application of LCZ may serve as new treatment options.

    Topics: Animals; Antifungal Agents; Canidae; Cats; Itraconazole; Japan; Terbinafine; Tinea

2023
Antifungal susceptibility of dermatophyte isolates from companion animals to ravuconazole.
    Veterinary dermatology, 2020, Volume: 31, Issue:2

    Topics: Animals; Antifungal Agents; Cats; Drug Resistance, Multiple, Fungal; Microbial Sensitivity Tests; Microsporum; Thiazoles; Tinea; Triazoles

2020
Tinea unguium caused by terbinafine-resistant Trichophyton rubrum successfully treated with fosravuconazole.
    The Journal of dermatology, 2019, Volume: 46, Issue:12

    Topics: Aged; Antifungal Agents; Drug Resistance, Fungal; Female; Hand Dermatoses; Humans; Onychomycosis; Terbinafine; Thiazoles; Tinea; Triazoles

2019